Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Contact person: Brian Roach
Telephone: +44 1312757620
E-mail: brian.roach@nhs.net
NUTS: UKM
Internet address(es)
Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/
Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Cardiology Stents.
Reference number: NP601/16
II.1.2) Main CPV code
33182300
II.1.3) Type of contract
Supplies
II.1.4) Short description
The Common Services Agency (more commonly known as National Services Scotland) (‘the Authority’) acting through its division Procurement, Commissioning and Facilities is undertaking this procurement of the supply and delivery of Cardiology Stents for use in Percutaneous Coronary Intervention procedures (Angioplasty) and related service and support (‘Products’) on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as ‘Participating Authorities’).
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
14 664 000.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
Drug Eluting & Bare Metal Stents
II.2.2) Additional CPV code(s)
33182300
II.2.3) Place of performance
NUTS code:
UKM
II.2.4) Description of the procurement
This requirement is for ‘workhorse’ Drug Eluting Stents and Bare Metal Stents for use in the majority of PCI cases. This requirement will include a range of stents with variable diameter and length, suitable for the majority of PCI cases.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 50
Price
/ Weighting:
50
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug (for the purpose of anti dual platelet therapy reduction)
II.2.2) Additional CPV code(s)
33182300
II.2.3) Place of performance
NUTS code:
UKM
II.2.4) Description of the procurement
This requirement is for innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug for the purpose of anti dual platelet therapy reduction. These stents would not be currently used for the majority of PCI cases.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 50
Price
/ Weighting:
50
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Bioresorbable Stents
II.2.2) Additional CPV code(s)
33182300
II.2.3) Place of performance
NUTS code:
UKM
II.2.4) Description of the procurement
This requirement is for Bioresorbable Stents- stents which once deployed, dissolve over time to leave no material within the artery.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 50
Price
/ Weighting:
50
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2016/S 156-282291
Section V: Award of contract
Lot No: 1
Title: Drug Eluting and Bare Metal Stents
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
06/12/2016
V.2.2) Information about tenders
Number of tenders received: 12
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Abbott Laboratories Limited (Abbott Vascular)
Abbott House, Vanwall Business Park, Vanwall Road
Maidenhead
SL6 4XE
UK
Telephone: +44 1628774683
Fax: +44 1628774608
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Boston Scientific Ltd
Breakspear Park, Breakspear Way, Hemel Hempstead
Herts
HP2 4TZ
UK
Telephone: +44 1442411753
Fax: +44 1442411601
NUTS: UKH23
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Biosensors Europe SA
Rue de Lausanne 29, Switzerland
Morges
1110
CH
Telephone: +41 218048020
NUTS: CH011
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 12 964 000.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 2
Title: Innovative Biodegradable Polymer and Polymer Free Stents with Quick Eluting or Coated Drug (for the purpose of anti dual platelet therapy reduction)
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
06/12/2016
V.2.2) Information about tenders
Number of tenders received: 10
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Boston Scientific Ltd
Breakspear Park, Breakspear Way, Hemel Hempstead
Herts
HP2 4TZ
UK
Telephone: +44 1442411753
Fax: +44 1442411601
NUTS: UKH23
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Biosensors Europe SA
Rue de Lausanne 29, Switzerland
Morges
1110
CH
Telephone: +41 218048020
NUTS: CH011
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Cardiologic Ltd
Innovation House, Allendale Road
Thirsk
YO7 3NX
UK
Telephone: +44 1845523132
NUTS: UKE
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1 300 000.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 3
Title: Bioresorbable Stents
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
06/12/2016
V.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Abbott Laboratories Limited (Abbott Vascular)
Abbott House, Vanwall Business Park, Vanwall Road
Maidenhead
SL6 4XE
UK
Telephone: +44 1628774683
Fax: +44 1628774608
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 400 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
(SC Ref: 474763)
VI.4) Procedures for review
VI.4.1) Review body
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Telephone: +44 1698794410
Internet address(es)
URL: http://www.nhsscotlandprocurement.scot.nhs.uk/
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
The Authority will notify economic operators who submitted a tender or (where no deselection process has previously been made) applied to be selected to tender, of its decision to award the Framework Agreement which notification will contain, among other information, a summary of the reasons as to why the economic operator was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 (ten) clear calendar days (or a minimum of 15 (fifteen) if the communication method used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
VI.5) Date of dispatch of this notice
15/12/2016